Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Januvia
Pharma
HHS says Merck lacks standing to sue over IRA price negotiations
Merck & Co. “lacks standing” to challenge Medicare drug pricing negotiations in court, the Biden administration argued in a new filing.
Fraiser Kansteiner
Sep 13, 2023 9:53am
Merck, Viatris close in on settlement in Januvia patent case
Mar 21, 2023 9:39am
Merck to FDA: Januvia contamination can be fixed this year
Jan 18, 2023 10:09am
Merck hooks up with Ginkgo Bioworks in manufacturing deal
Oct 11, 2022 7:00am
Merck prevails in Januvia patent lawsuit against Viatris
Sep 22, 2022 9:39am
Merck is the latest drugmaker to fall victim to nitrosamine woes
Aug 10, 2022 8:10am
